Available Technologies
# of Displayed Technologies: 1 / 1
Combination Agent Approach for Improved Expansion and Mobilization of Hematopoietic Stem Cells
TS-037629 — Combined treatment of plerixafor and Flt3L better mobilize stem cells and do not exacerbate graft-versus-host disease following transplatation.
Hematopoietic stem cell transplantation (HSCT) is used in patients with hematologic malignancies resulting from irradiation and graft-versus-tumor effects. However, patients who undergone HSCT may suffer complications such as graft-versus-host disease (GVHD), infection, and relapse. The most commo…
- College: College of Medicine (COM)
- Inventors: Yu, Jianhua; Caligiuri, Michael; Devine, Steven
- Licensing Officer: Taysavang, Panya
